Scaling a hyper-growth tech company
HealthVerity’s journey from an unknown startup to a major disrupter in the Healthcare industry ...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
HealthVerity’s journey from an unknown startup to a major disrupter in the Healthcare industry ...
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Written by Emery Niemiec I recently attended the 2022 INFORMS Business Analytics Conference and had...
Exploring the impacts and benefits of a real-world data strategy for long-term care insurance...
Why government and public health agencies contract for the HealthVerity IPGE platform as a trusted...
In the first installment of our HealthVerity IPGE blog series covering the four foundational...
How real-world data (RWD) from open and closed claims and beyond can be layered to better explore...
Patient Identity Resolution: The next era of healthcare data interoperability The HealthVerity...
The intrinsic role of real-world data to help determine the necessity for booster shots as new...
In a recent HealthVerity LIVE webinar, we took an in-depth look at how the HealthVerity IPGE...
Artificial intelligence is moving quickly into healthcare research, but one question still comes up: can you trust it? If an AI platform is going to support study design, cohort definition, analysis and reporting, RWE teams need confidence that the o...